Sutton Wealth Advisors Inc. Myriad Genetics Inc Transaction History

Sutton Wealth Advisors Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$15.26 - $23.75 $17,365 - $27,027	-1,138 Closed	0 $0
Q3 2022 Nov 07, 2023	BUY	$18.21 - $27.88 $345 - $529	19 Added 1.7%	1,138 $21.7 Million
Q2 2022 Nov 07, 2023	SELL	$16.45 - $25.88 $148 - $232	-9 Reduced 0.8%	1,119 $20.3 Million
Q1 2022 Nov 07, 2023	SELL	$22.67 - $28.01 $249 - $308	-11 Reduced 0.97%	1,128 $28.4 Million
Q4 2021 Nov 07, 2023	BUY	$24.13 - $32.63 $482 - $652	20 Added 1.79%	1,139 $31.4 Million
Q3 2020 Nov 07, 2023	BUY	$11.25 - $14.75 $8,887 - $11,652	790 Added 240.12%	1,119 $14.6 Million
Q1 2020 Nov 07, 2023	SELL	$9.78 - $29.53 $6,601 - $19,932	-675 Reduced 67.23%	329 $4.71 Million
Q2 2019 Nov 06, 2023	SELL	$22.67 - $35.0 $3,445 - $5,320	-152 Reduced 13.15%	1,004 $27.9 Million
Q1 2019 Nov 06, 2023	BUY	$26.93 - $34.7 $4,093 - $5,274	152 Added 15.14%	1,156 $38.4 Million
Q2 2017 Nov 06, 2023	SELL	N/A	-255 Reduced 20.25%	1,004 $25.9 Million
Q1 2017 Nov 06, 2023	BUY	N/A	1,259	1,259 $24.2 Million

227

92M

297K

20.7K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.14B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.